BIIB Biogen Inc.
BIIB Biogen Inc.
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 3 scans as of 2026-10-16 3 bull converging
POC $174.48 · VWAP $187.32 · +24.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
BIIB Price Structure
Loading timeframes…
Peers
Every watchlist BIIB belongs to, members best 30-day change first — BIIB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $2.74B, diluted EPS $0.66, net income $98M (the desk's provider cache). Across the print the stock moved -3.0% (close before → first close after).
full note →Against street estimates
How BIIB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about BIIB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 10 days ago · Oct 7
- Biogen Inc. (BIIB) latest stock news and headlines – Yahoo Finance
- Latest Biogen Stock News | NASDAQ:BIIB | Benzinga
- BIIB - Biogen Inc Earnings Reports, Summaries & Call Transcripts | Morningstar
- Biogen Q2 2026 results and Apellis acquisition | BIIB Quarterly Report (10-Q)
- Biogen Inc (BIIB) Live Share Price, Invest From India
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
BIIB research tape
147 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.